S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/BVF Partners/Q2 2022

BVF Partners

Period: Q2 2022 Β· Filed: 2022-08-15
View on SEC EDGAR β†—
AUM
$2.07B
Total portfolio value
Positions
79
Reported securities
Top Holding
RPTX
5.6% $116.0M
QoQ Changes
+7 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2022-08-15) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
RPTXREPARE THERAPEUTICS INC$116.0M5.60%β€”β€”
5.6%
MLTXMOONLAKE IMMUNOTHERAPEUTICS$114.2M5.51%$5.25$18.95+260.9%
5.5%
RCUSARCUS BIOSCIENCES INC$100.4M4.85%$25.34$30.33+19.7%
4.8%
CGEMCULLINAN ONCOLOGY INC$96.3M4.65%$12.82$17.63+37.5%
4.7%
GHRSGH RESEARCH PLC$92.6M4.47%$9.98$27.01+170.6%
4.5%
MRUSMERUS N V$92.4M4.46%β€”β€”
4.5%
KYMRKYMERA THERAPEUTICS INC$81.5M3.94%$19.69$113.51+476.5%
3.9%
XOMAXOMA CORP DEL$78.7M3.80%$22.28$43.00+93.0%
3.8%
RLAYRELAY THERAPEUTICS INC$73.4M3.55%$16.75$18.65+11.3%
3.5%
CRNXCRINETICS PHARMACEUTICALS IN$68.6M3.31%$18.65$42.23+126.4%
3.3%
KURAKURA ONCOLOGY INC$58.7M2.84%$18.33$11.10-39.4%
2.8%
ACRSACLARIS THERAPEUTICS INC$55.5M2.68%$13.96$5.56-60.2%
2.7%
CTICCTI BIOPHARMA CORP$53.3M2.57%β€”β€”
2.6%
EQRXEQRX INC$49.9M2.41%β€”β€”
2.4%
XENEXENON PHARMACEUTICALS INC$48.6M2.35%$30.42$60.96+100.4%
2.4%
IONSIONIS PHARMACEUTICALS INC$47.3M2.28%$37.02$81.80+121.0%
2.3%
SNDXSYNDAX PHARMACEUTICALS INC$45.4M2.19%$19.24$21.82+13.4%
2.2%
RVMDREVOLUTION MEDICINES INC$44.0M2.12%$19.49$189.24+871.0%
2.1%
ITOSITEOS THERAPEUTICS INC$39.7M1.92%β€”β€”
1.9%
IDYAIDEAYA BIOSCIENCES INC$38.6M1.86%$13.80$37.65+172.8%
1.9%
CNTACENTESSA PHARMACEUTICALS PLC$33.6M1.62%$4.87$40.50+731.6%
1.6%
RLMDRELMADA THERAPEUTICS INC$31.5M1.52%$18.99$6.28-66.9%
1.5%
CINCCINCOR PHARMA INC$31.0M1.50%β€”β€”
1.5%
OLMAOLEMA PHARMACEUTICALS INC$31.0M1.50%$4.07$12.64+210.6%
1.5%
FDMT4D MOLECULAR THERAPEUTICS IN$28.0M1.35%$6.98$13.00+86.3%
1.4%
ACIUAC IMMUNE SA$26.8M1.30%$3.61$2.51-30.5%
1.3%
LXRXLEXICON PHARMACEUTICALS INC$26.3M1.27%$1.86$2.32+24.7%
1.3%
VSTMXXXXVERASTEM INC$23.2M1.12%β€”β€”
1.1%
PNTPOINT BIOPHARMA GLOBAL INC$22.9M1.11%β€”β€”
1.1%
NUVLNUVALENT INC$22.6M1.09%$13.56$123.73+812.5%
1.1%

Quarter-on-Quarter Activity

Q2 2022 vs. Q1 2022

New Positions (7)

TickerIssuerNotionalSince Filing
MLTXMOONLAKE IMMUNOTHERAPEUTICS$114.2M+260.9%
IONSIONIS PHARMACEUTICALS INC$47.3M+121.0%
ANNXANNEXON INC$14.3M
ETNB89BIO INC$12.6M
HLVXHILLEVAX INC$4.2M
CLDXCELLDEX THERAPEUTICS INC NEW$4.2M
CALACALITHERA BIOSCIENCES INC$1.1M

Exited Positions (8)

TickerIssuerNotional
ARGXARGENX SE$99.7M
LKFTGALAPAGOS NV$64.9M
NGMNGM BIOPHARMACEUTICALS INC$14.6M
DAWNDAY ONE BIOPHARMACEUTICALS I$8.0M
GNCAGENOCEA BIOSCIENCES INC$5.0M
CALACALITHERA BIOSCIENCES INC$3.8M
RDUSRADIUS HEALTH INC$3.3M
ABOSACUMEN PHARMACEUTICALS INC$1.1M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
CNTACENTESSA PHARMACEUTICALS PLC$17.8M+292.7%+731.6%
NUVLNUVALENT INC$13.0M+141.7%+812.5%
SPROSPERO THERAPEUTICS INC$-11.5M+94.9%
IDYAIDEAYA BIOSCIENCES INC$20.7M+74.6%+172.8%
CNCECONCERT PHARMACEUTICALS INC$7.7M+61.1%
FDMT4D MOLECULAR THERAPEUTICS IN$-12.3M+50.4%+86.3%
COGTCOGENT BIOSCIENCES INC$8.9M+47.3%
RPTXREPARE THERAPEUTICS INC$32.6M+41.5%

Trimmed (8)

TickerIssuerNotionalShares Ξ”Since Filing
VYGRVOYAGER THERAPEUTICS INC$-8.2M-88.2%
PTGXPROTAGONIST THERAPEUTICS INC$-90.3M-73.5%
GBIOGENERATION BIO CO$-10.3M-44.5%
ALPNALPINE IMMUNE SCIENCES INC$-3.4M-19.8%
EQRXEQRX INC$0.3M-11.5%
CINCCINCOR PHARMA INC$0.5M-5.2%
PIRSPIERIS PHARMACEUTICALS INC$-6.6M-4.7%
RLAYRELAY THERAPEUTICS INC$-62.2M-3.2%+11.3%
← Back to Hedge Funds